References
- Dritschilo A, Mossman K, Gray M, Sreevalsan T. Potentiation of radiation injury by interferon. Am J Clin Oncol 1982; 5: 79–82
- Namba M, Yamamoto S, Tanaka H, Kanamori T, Nobuhara M, Kimoto T. In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt-60 gamma ray by interferon on human neoplastic cells. Cancer 1984; 54: 2262–7
- Chang A YC, Keng P C. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res 1987; 47: 4338–41
- Cantell K, Hirvonen S, Kauppinen H-L, Myllylä G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol 1981; 78: 29
- Cantell K, Hirvonen S, Koistinen V. Partial purification of human leukocyte interferon on a large scale. Methods Enzymol 1981; 78: 499–505
- Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 204–14
- Holsti L R, Mattson K, Niiranen A, et al. Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. Int J Radiation Oncol Biol Phys 1987; 13: 1161–6
- Chang A YC, Keng P. Radiation (XRT) sensitization by interferons (IFNs), preclinical and clinical studies. J Interferon Res 1987; 7: 681
- Mattson K, Holsti L R, Niiranen A, et al. Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer. J Biol Response Mod 1985; 4: 8–17
- Torrisi J, Berg C, Bonnem E, Dritschilo A. The combined use of interferon and radiotherapy in cancer management. Semin Oncol 1986; 13: 78–83